According to BioMarin Pharmaceutical's latest financial reports the company has HK$44.00 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $HK$43.92 B | 13.59% |
2023-12-31 | $HK$38.67 B | 7.52% |
2022-12-31 | $HK$35.96 B | 8.13% |
2021-12-31 | $HK$33.26 B | 4.5% |
2020-12-31 | $HK$31.83 B | 30.9% |
2019-12-31 | $HK$24.31 B | 4.63% |
2018-12-31 | $HK$23.24 B | 5.91% |
2017-12-31 | $HK$21.94 B | 2.3% |
2016-12-31 | $HK$21.45 B | 15.28% |
2015-12-31 | $HK$18.60 B | 57.02% |
2014-12-31 | $HK$11.85 B | 13.96% |
2013-12-31 | $HK$10.39 B | 32.08% |
2012-12-31 | $HK$7.87 B | 31.13% |
2011-12-31 | $HK$6.00 B | 7.57% |
2010-12-31 | $HK$5.58 B | 123.44% |
2009-12-31 | $HK$2.49 B | 16.84% |
2008-12-31 | $HK$2.13 B | 46.07% |
2007-12-31 | $HK$1.46 B | 59.76% |
2006-12-31 | $HK$0.91 B | -252.55% |
2005-12-31 | $-HK$0.61 Billion | 13.69% |
2004-12-31 | $-HK$0.53 Billion | -157.83% |
2003-12-31 | $HK$0.91 B | 18.87% |
2002-12-31 | $HK$0.76 B | -38.23% |
2001-12-31 | $HK$1.24 B |